2025 second_quarter Filing
Q2Income
$50K
Filed
July 18, 2025
Lobbying Activities
Medicare/MedicaidView all
Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Taxation/Internal Revenue CodeView all
Tax legislation affecting the Orphan Drug Tax Credit and the Research and Development Tax Credit.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Health Issues
Lobbyists (7)
ms MELINDA M MAXFIELD
LAURA M SIMMONS
Advisor, Office of Legislative Affairs, Dept of Homeland Security
CHRISTOPHER E. WILCOX
LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
JEANNE HAGGERTY
Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member